The most commonly reported side effects are mild and include injection site reactions (redness, pain, swelling) at subcutaneous administration sites, typically transient and manageable with proper injection technique and site rotation
Test subjects were included in the study if they were at least 18 years of age with a type 2 diabetes diagnosis and stable treatment with metformin, thiazolidinediones, and/or sulfonylureas, for at least 90 days prior to the initiation of the experiment
Amidst this positive trend in diabetes spend rests an uncomfortable reality : it may depend on a potentially permanent pharmaceutical commitment
It is not known if Saxenda is safe and effective in children aged 12 to 17 years with type 2 diabetes
By making a purchase from Montreal Peptides, you certify that you are a minimum of 18 years old, that products will be utilized exclusively for legitimate research purposes, and that you accept complete responsibility for adhering to all relevant laws within your jurisdiction.
Think about the true cost of a failed experiment
